Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma: Results of the Compassionate Use or the Expanded Access Program in Spain

  1. de la Rubia, J.
  2. Alonso, R.
  3. Clavero, M.E.
  4. Askari, E.
  5. García, A.
  6. Antón, C.
  7. Fernández, M.
  8. Escalante, F.
  9. García, A.
  10. Rios-Tamayo, R.
  11. Conesa, V.
  12. Bermúdez, M.A.
  13. Merchán, B.
  14. Velasco, A.E.
  15. Blanchard, M.J.
  16. Sampol, A.
  17. Gainza, E.
  18. Hernández, P.M.
  19. Alegre, A.
Journal:
Cancers

ISSN: 2072-6694

Year of publication: 2023

Volume: 15

Issue: 11

Type: Article

DOI: 10.3390/CANCERS15112964 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus